Chemoinformaics analysis of butyl (butoxycarbonyl)methyl phthalate
| Molecular Weight | 336.384 | nRot | 10 |
| Heavy Atom Molecular Weight | 312.192 | nRig | 9 |
| Exact Molecular Weight | 336.157 | nRing | 1 |
| Solubility: LogS | -4.302 | nHRing | 0 |
| Solubility: LogP | 3.852 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 48 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 1 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 6 |
| nHA | 6 | APOL | 50.875 |
| nHD | 0 | BPOL | 31.889 |
| QED | 0.371 |
| Synth | 1.95 |
| Natural Product Likeliness | -0.342 |
| NR-PPAR-gamma | 0.02 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.914 |
| Pgp-sub | 0 |
| HIA | 0.002 |
| CACO-2 | -4.563 |
| MDCK | 0.0000334 |
| BBB | 0.065 |
| PPB | 0.911346 |
| VDSS | 0.497 |
| FU | 0.0410037 |
| CYP1A2-inh | 0.979 |
| CYP1A2-sub | 0.184 |
| CYP2c19-inh | 0.945 |
| CYP2c19-sub | 0.064 |
| CYP2c9-inh | 0.897 |
| CYP2c9-sub | 0.143 |
| CYP2d6-inh | 0.497 |
| CYP2d6-sub | 0.079 |
| CYP3a4-inh | 0.55 |
| CYP3a4-sub | 0.128 |
| CL | 13.57 |
| T12 | 0.688 |
| hERG | 0.146 |
| Ames | 0.008 |
| ROA | 0.002 |
| SkinSen | 0.844 |
| Carcinogencity | 0.128 |
| EI | 0.979 |
| Respiratory | 0.016 |
| NR-Aromatase | 0.071 |
| Antiviral | Yes |
| Prediction | 0.759639 |